Healthcare & Medical Devices Global On demand · 24-48h

Global Below-the-knee Balloon Dilatation Catheter Market Strategic Research Report

Global Below-the-knee Balloon Dilatation Catheter Market Str…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Below-the-knee Balloon Dilatation Catheter Market
$2.74B2025
6.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: With Sheath 5F, With Sheath 4F

By Application: Hospital, Clinic

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Boston Scientific, Medtronic, Cook Medical, Terumo Interventional Systems, BD (Becton Dickinson), Biotronik, Abbott Laboratories, Cordis, B. Braun Melsungen, AngioDynamics, Surmodics, iVascular, Zylox-Tonbridge, MicroPort Endovascular, Lepu Medical, Acotec Scientific, OrbusNeich, Nipro

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 142 pages
Market size 2025
$2.74B
Billion USD
Forecast CAGR
6.7%
2025-2032
Forecast 2032
$4.3B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Below-the-knee Balloon Dilatation Catheter market size is predicted to grow from US$ 2,739 million in 2025 to US$ 4,306 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.

Below-the-knee Balloon Dilatation Catheter refers to a percutaneous transluminal angioplasty catheter designed to dilate narrowed or occluded arteries below the knee, especially small and distal infrapopliteal vessels. The catheter is inserted over a guidewire and advanced through the vascular system to the lesion, where the balloon is inflated to restore vessel lumen and improve blood flow to the lower leg and foot. These catheters are typically designed with low crossing profile, long shaft length, small balloon diameter, long balloon length, hydrophilic coating, high pushability, high trackability and compatibility with 0.014" or 0.018" guidewires. In this report, the market mainly includes standard BTK PTA balloons, low-profile 0.014" BTK balloons, 0.018" infrapopliteal balloons, long BTK balloons, high-pressure BTK balloons, pedal-access balloons and peripheral balloons specifically marketed for below-the-knee or infrapopliteal procedures. The 2025 benchmark ASP is US$620 / unit, sales volume is 4,516.13k units, and average gross margin is 60%. The upstream industry chain includes balloon polymers, catheter shaft materials, guidewire-compatible tubing, hydrophilic coatings, radiopaque marker bands, adhesives, hypotubes, hubs, inflation ports, sterilization packaging and precision extrusion materials. The midstream includes balloon forming, catheter extrusion, shaft bonding, marker band assembly, coating, balloon folding, crimping, leak testing, burst pressure testing, trackability testing, sterilization, packaging, regulatory approval and quality inspection. The downstream includes interventional radiology departments, vascular surgery departments, cardiology catheterization labs, diabetic foot centers, limb salvage centers, hospitals, ambulatory vascular centers, medical device distributors and group purchasing organizations.

Below-the-knee balloon dilatation catheters are an important device category in limb salvage and peripheral artery disease intervention. Demand is driven by the rising prevalence of diabetes, chronic limb-threatening ischemia, peripheral artery disease, aging populations and greater clinical preference for minimally invasive endovascular therapy before surgical bypass or amputation. BTK lesions are often long, calcified, diffuse and located in small tortuous vessels, so catheter deliverability, crossing profile, pushability, hydrophilic coating, long balloon length and controlled inflation performance are critical. Compared with above-the-knee PTA balloons, BTK balloons require smaller diameters, longer shaft options and better distal vessel navigation. Compared with drug-coated balloons, plain BTK balloon dilatation catheters remain important because infrapopliteal DCB adoption has been more selective and plain PTA is still widely used in many markets. Market growth is supported by more diabetic foot programs, limb salvage centers, outpatient vascular centers, pedal access techniques and new low-profile catheter designs. However, the market faces pressure from reimbursement limits, price-based tenders, product commoditization, restenosis after plain balloon angioplasty, competition from drug-coated balloons, scoring balloons, atherectomy, intravascular lithotripsy and bypass surgery. Future competition will focus on ultra-low crossing profile, longer balloons, improved rewrap, faster deflation, higher rated burst pressure, better torque response, pedal access compatibility, radial-to-peripheral compatibility and integration with vessel preparation workflows.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Below-the-knee Balloon Dilatation Catheter market?

What factors are driving Below-the-knee Balloon Dilatation Catheter market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Below-the-knee Balloon Dilatation Catheter market opportunities vary by end market size?

How does Below-the-knee Balloon Dilatation Catheter break out by Type, by Application?

This report presents a comprehensive overview of the global Below-the-knee Balloon Dilatation Catheter market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • With Sheath 5F
  • With Sheath 4F

Segment by Balloon Length

  • Short Balloon (≤ 40 mm)
  • Medium Balloon (40 – 100 mm)
  • Long Balloon (> 100 mm)

Segment by Drug Coating Type

  • Paclitaxel-Coated Balloons
  • Sirolimus-Coated Balloons
  • Non-Drug-Coated Balloons

Segment by Application

  • Hospital
  • Clinic

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Below-the-knee Balloon Dilatation Catheter market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Below-the-knee Balloon Dilatation Catheter Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.74B
2025
Forecast
$4.3B
2032
CAGR
6.7%
2025–2032
Regions
5
global
Key companies
Boston ScientificMedtronicCook MedicalTerumo Interventional SystemsBD (Becton Dickinson)BiotronikAbbott LaboratoriesCordis
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
With Sheath 5FWith Sheath 4F
By Application
HospitalClinic

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 With Sheath 5F
  • 3.1.3 With Sheath 4F
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Boston Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Medtronic
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Cook Medical
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Terumo Interventional Systems
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 BD (Becton Dickinson)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Biotronik
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Abbott Laboratories
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Cordis
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 B. Braun Melsungen
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 AngioDynamics
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Surmodics
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 iVascular
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Zylox-Tonbridge
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 MicroPort Endovascular
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Lepu Medical
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Acotec Scientific
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 OrbusNeich
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Nipro
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Below-the-knee Balloon Dilatation Catheter market?
The global Below-the-knee Balloon Dilatation Catheter market is estimated at US$ 2.74 billion in 2025 (base year) and is projected to reach US$ 4.31 billion by 2032.
What is the forecast CAGR for the Below-the-knee Balloon Dilatation Catheter market?
The market is expected to grow at a CAGR of 6.7% from 2026 to 2032, expanding from US$ 2.74 billion in 2025 to US$ 4.31 billion in 2032, roughly 1.6 times its base-year value.
What is Below-the-knee Balloon Dilatation Catheter?
Below-the-knee Balloon Dilatation Catheter refers to a percutaneous transluminal angioplasty catheter designed to dilate narrowed or occluded arteries below the knee, especially small and distal infrapopliteal vessels. The catheter is inserted over a guidewire and advanced through the vascular system to the lesion, where the balloon is inflated to restore vessel lumen and improve blood flow to the lower leg and foot.
How is the Below-the-knee Balloon Dilatation Catheter market segmented by type?
By type, the market is segmented into With Sheath 5F and With Sheath 4F.
What are the key applications of Below-the-knee Balloon Dilatation Catheter?
Key applications covered include Hospital and Clinic.
Which companies are profiled in the Below-the-knee Balloon Dilatation Catheter market report?
Key players profiled include Boston Scientific, Medtronic, Cook Medical, Terumo Interventional Systems, BD (Becton Dickinson), Biotronik, Abbott Laboratories and Cordis, among 18 companies covered in total.
What geographies does the Below-the-knee Balloon Dilatation Catheter market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Below-the-knee Balloon Dilatation Catheter?
Demand is driven by the rising prevalence of diabetes, chronic limb-threatening ischemia, peripheral artery disease, aging populations and greater clinical preference for minimally invasive endovascular therapy before surgical bypass or amputation.
Who should buy the Below-the-knee Balloon Dilatation Catheter market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital and Clinic, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Below-the-knee Balloon Dilatation Catheter market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.